Literature DB >> 21422148

The PhaSeal® system: impact of its use on workplace contamination and duration of chemotherapy preparation.

B Favier1, H Labrosse, L Gilles-Afchain, C Cropet, D Perol, N Chaumard, J F Latour, P Hild.   

Abstract

PURPOSE: The primary objective of this study was to compare the levels of environmental contamination before and after the introduction of PhaSeal® (closed-system drug transfer device) in two hospital pharmacies. Our secondary objective was to assess the impact of the device on the duration of drug preparation compared to procedures involving the use of needles and syringes.
METHODS: The study involved two French hospitals, which prepared antineoplastic chemotherapy using a biological safety cabinet and an isolator. Five skilled pharmacy technicians at each hospital prepared a total of 100 chemotherapy preparations using the standard procedure and 100 using the PhaSeal® system. To control for possible contamination occurring in the course of the procedure, we used fluorescein which becomes fluorescent when exposed to UV light. To reply the second objective, we timed the duration of the different steps of the manipulation.
RESULTS: Our findings showed a major reduction in the contamination of the work environment when using the PhaSeal® system for drug preparation. Reduction rates higher than 93% were obtained, whatever the type of protection used. On the duration of preparation, our results indicate that this duration would be approximately 1 h longer for the preparation of 100 samples.
CONCLUSION: In conclusion, this study clearly establishes the benefit of using PhaSeal® for protecting the staff members who work with hazardous agents. It also indicates that the duration of drug preparation is not impacted by the use of the system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422148     DOI: 10.1177/1078155211401454

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.809


  7 in total

1.  Safe handling of cytotoxics: guideline recommendations.

Authors:  A C Easty; N Coakley; R Cheng; M Cividino; P Savage; R Tozer; R E White
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

Review 2.  Identification of Knowledge Gaps Regarding Healthcare Workers' Exposure to Antineoplastic Drugs: Review of Literature, North America versus Europe.

Authors:  Chun-Yip Hon; Cris Barzan; George Astrakianakis
Journal:  Saf Health Work       Date:  2014-06-11

3.  Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study.

Authors:  Nicolas Simon; Michèle Vasseur; Marine Pinturaud; Marion Soichot; Camille Richeval; Luc Humbert; Michèle Lebecque; Ousseini Sidikou; Christine Barthelemy; Pascal Bonnabry; Delphine Allorge; Bertrand Décaudin; Pascal Odou
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

4.  Cost Analysis of Using a Closed-System Transfer Device (CSTD) for Antineoplastic Drug preparation in a Malaysian Government-Funded Hospital

Authors:  Huan Keat Chan; Yik Ming Lim
Journal:  Asian Pac J Cancer Prev       Date:  2016-11-01

5.  Implementation and validation of an in-house combined fluorescein/media-fill test to qualify radiopharmacy operators.

Authors:  Cyril Fersing; Emmanuel Deshayes; Sarah Langlet; Laurence Calas; Vincent Lisowski; Pierre Olivier Kotzki
Journal:  EJNMMI Radiopharm Chem       Date:  2021-01-07

Review 6.  Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.

Authors:  Kurinchi Selvan Gurusamy; Lawrence Mj Best; Cynthia Tanguay; Elaine Lennan; Mika Korva; Jean-François Bussières
Journal:  Cochrane Database Syst Rev       Date:  2018-03-27

7.  Salient Features and Outline of the Joint Japanese Guidelines for Safe Handling of Cancer Chemotherapy Drugs.

Authors:  Kiyoko Kanda; Kazue Hirai; Keiko Iino; Hisanaga Nomura; Hisateru Yasui; Taro Kano; Chisato Ichikawa; Sumiko Hiura; Tomoko Morita; Ayako Mitsuma; Hiroko Komatsu
Journal:  Asia Pac J Oncol Nurs       Date:  2017 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.